CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.74 ($18,500)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $0.74 ($14,796)
- 4 Open-market buy Chief Legal Officer, Corp. Sec bought 6,000 shares at $0.85 ($5,095)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- S-3 Offering Registration Statement
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
Page 10 of 16 · 309 filings